Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-25-119914
Filing Date
2025-05-14
Accepted
2025-05-14 16:47:13
Documents
6
Effectiveness Date
2025-05-14

Document Format Files

Seq Description Document Type Size
1 S-8 d901324ds8.htm S-8 39046
2 EX-4.3 d901324dex43.htm EX-4.3 7638
3 EX-5.1 d901324dex51.htm EX-5.1 8989
4 EX-23.2 d901324dex232.htm EX-23.2 1631
5 EX-FILING FEES d901324dexfilingfees.htm EX-FILING FEES 15380
6 GRAPHIC g901324dsp1.jpg GRAPHIC 3884
  Complete submission text file 0001193125-25-119914.txt   79173
Mailing Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472
Business Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472 617-207-8979
Acrivon Therapeutics, Inc. (Filer) CIK: 0001781174 (see all company filings)

EIN.: 825125532 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-287277 | Film No.: 25946645
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)